Pennsylvania Drug Discovery Institute is located in Doylestown, PA. The organization was established in 2011. According to its NTEE Classification (S05) the organization is classified as: Research Institutes & Public Policy Analysis, under the broad grouping of Community Improvement & Capacity Building and related organizations. As of 06/2015, Pennsylvania Drug Discovery Institute employed 6 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Pennsylvania Drug Discovery Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
Describe the Organization's Mission:
Part 3 - Line 1
TO PROVIDE SERVICE TO THE SCIENTIFIC COMMUNITY, SUCH AS BY WORKPLACE REENTRY AND NETWORKING ACTIVITIES, AS WELL AS ENTREPRENEURSHIP MENTORING. TO CONDUCT INNOVATIVE, COLLABORATIVE RESEARCH TO ACCELERATE DRUG DISCOVERY AND THE TRANSLATION OF DISCOVERIES INTO DEVELOPMENT CANDIDATES FOR HUMAN CLINICAL TRIALS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
CONDUCTED INNOVATIVE, COLLABORATIVE RESEARCH TO ACCELERATE DRUG DISCOVERY AND THE TRANSLATION OF DISCOVERIES INTO DEVELOPMENT CANDIDATES FOR HUMAN CLINICAL TRIALS.
PROVIDED SERVICE TO THE SCIENTIFIC COMMUNITY, SUCH AS BY WORKPLACE REENTRY AND NETWORKING ACTIVITIES, AS WELL AS ENTREPRENEURSHIP MENTORING.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Allen B Reitz Ph D President | OfficerTrustee | 1.5 | $0 |
Bruce E Maryanoff Ph D Vice Preside | OfficerTrustee | 0.1 | $0 |
Joseph F Aceto Ph D Director | Trustee | 0.1 | $0 |
Paul S Anderson Ph D Director | Trustee | 0.1 | $0 |
Bashar W Hanna Ph D Director | Trustee | 0.1 | $0 |
Ned D Heindel Ph D Director | Trustee | 0.1 | $0 |